Bilimsel Yayınlar
1. Toplumdan Kökenli Pnömoni Nedeniyle Hastanede Yatan Yaşlı Hastaların (> 65 Yaş) Özellikleri ve Ekonomik Yükü – Abant Medical Journal, 2022; Katgı N., Çimen P., Ayrancı A., Tuksavul F.F.
2. Telisotuzumab Vedotin Monotherapy in Previously Treated c-MET–Overexpressing Non-Squamous EGFR Wild-Type Advanced NSCLC: LUMINOSITY Trial – Updated Analysis – Journal of Thoracic Oncology, 2025; Katgı N. ve ark.
3. Telisotuzumab Vedotin Monotherapy in NSCLC: Primary Analysis of LUMINOSITY Trial – Journal of Clinical Oncology, 2024; Katgı N. ve ark.
4. Efficiency and Reliability of Bronchoscopic Lung Volume Reduction Coil Application in Severe Emphysema – 2024; Katgı N. ve ark.
5. Comparison of Alectinib and Crizotinib in ALK Positive Advanced NSCLC: Real-Life Data – Thoracic Research and Practice, 2023; Katgı N. ve ark.
6. Relationship Between Thyroid Transcription Factor 1 (TTF 1) Positivity and EGFR Mutation in Lung Adenocarcinoma – Eurasian Journal of Pulmonology, 2023; Katgı N. ve ark.
7. COVID-19 Hastalarında Prognostik Faktörler ve Eozinofillerin Rolü – Journal of İzmir Chest Hospital, 2023; Katgı N. ve ark.
8. Prediction of EGFR and ALK Mutations by 18F FDG PET/CT Texture Analysis in Lung Adenocarcinoma – Nüklearmedizin, 2022; Katgı N. ve ark.
9. Prognostic Value of 18F FDG PET/CT Metabolic Parameters in Advanced Lung Adenocarcinoma – Molecular Imaging and Radionuclide Therapy, 2022; Katgı N. ve ark.
10. Real-Life Comparison of Afatinib vs Erlotinib in Rare EGFR Exon 18/20 Mutations: TOG Study – Journal of Cancer Research and Clinical Oncology, 2022; Katgı N. ve ark.
11. Complication and Cost Analysis of Transbronchial Lung Cryobiopsy and Awake VATS in Interstitial Lung Disease Diagnosis – Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 2022; Katgı N. ve ark.
12. Diagnostic Efficacy of EBUS TBNA in Benign Diseases in High Tuberculosis Prevalence Regions – 2020; Katgı N. ve ark.
13. Comparison of TBLC and Conventional Transbronchial Biopsy in the Diagnosis of Parenchymal Lung Diseases – 2019; Katgı N. ve ark.
